Details

Klinični pomen določanja koncentracije zgodnjega prostatičnega karcinomskega antigena 2 pri bolnikih z rakom prostate : [diplomska naloga]
ID Frankovič, Maja (Author), ID Osredkar, Joško (Mentor) More about this mentor... This link opens in a new window

URLURL - Presentation file, Visit http://www.ffa.uni-lj.si/fileadmin/datoteke/Knjiznica/diplome/2013/Frankovic_Maja_dipl_nal_2013.pdf This link opens in a new window

Language:Slovenian
Keywords:zgodnji prostatični karcinomski antigen 2, prostatični specifični antigen, benigna hiperplazija prostate, diagnostična uporabnost, zdravljenje raka prostate, tumorski označevalci
Work type:Undergraduate thesis
Typology:2.11 - Undergraduate Thesis
Organization:FFA - Faculty of Pharmacy
Place of publishing:Ljubljana
Publisher:[M. Frankovič]
Year:2013
Number of pages:XI, 75 str.
PID:20.500.12556/RUL-71361 This link opens in a new window
UDC:616.65-006-074(043.2)
COBISS.SI-ID:3549041 This link opens in a new window
Publication date in RUL:10.07.2015
Views:2936
Downloads:330
Metadata:XML DC-XML DC-RDF
:
FRANKOVIČ, Maja, 2013, Klinični pomen določanja koncentracije zgodnjega prostatičnega karcinomskega antigena 2 pri bolnikih z rakom prostate : [diplomska naloga] [online]. Bachelor’s thesis. Ljubljana : M. Frankovič. [Accessed 3 September 2025]. Retrieved from: http://www.ffa.uni-lj.si/fileadmin/datoteke/Knjiznica/diplome/2013/Frankovic_Maja_dipl_nal_2013.pdf
Copy citation
Share:Bookmark and Share

Secondary language

Language:English
Title:The clinical significance of determining the concentration of early prostate cancer antigen 2 in prostate cancer patients

Similar documents

Similar works from RUL:
  1. Comparison of fecal microbiota of children with chronic inflammatory bowel disease and functional bowel disorders
  2. Kakovost življenja pri parih s kronično vnetno črevesno boleznijo ter relacijska družinska terapija
  3. Vitamin and mineral deficiency in patients with inflammatory bowel disease
  4. ǂThe ǂimportance of undetectable inflicamab t(h!)rough levels for clinical outcome of patients with inflammatory bowel disease
  5. Infliximab through as a biomarker for inflammatory bowel disease
Similar works from other Slovenian collections:
  1. Quality of life of children with chronic inflammatory bowel disease
  2. Izolacija in karakterizacija bakterije Clostridium difficile pri hospitaliziranih bolnikih s kronično vnetno črevesno boleznijo
  3. Expression and epigenetic profiles in patients with chronic inflammatory bowel disease
  4. Biomarkers of response to vedolizumab in inflammatory bowel diseases patients
  5. Nursing care of child with chronic inflammatory bowel (Crohn's disease)

Back